Estradiol inhibits HIV-1BaL infection and induces CFL1 expression in peripheral blood mononuclear cells and endocervical mucosa

Abstract An inhibitory effect of estradiol (E2) on HIV-1 infection was suggested by several reports. We previously identified increased gene expression of actin-binding protein cofilin 1 (CFL1) in endocervix in the E2-dominated proliferative phase of the menstrual cycle. Actin cytoskeleton has an in...

Full description

Bibliographic Details
Main Authors: N. Verma, S. Mukhopadhyay, P. Barnable, M. G. Plagianos, N. Teleshova
Format: Article
Language:English
Published: Nature Portfolio 2022-04-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-10163-6
_version_ 1828405958000246784
author N. Verma
S. Mukhopadhyay
P. Barnable
M. G. Plagianos
N. Teleshova
author_facet N. Verma
S. Mukhopadhyay
P. Barnable
M. G. Plagianos
N. Teleshova
author_sort N. Verma
collection DOAJ
description Abstract An inhibitory effect of estradiol (E2) on HIV-1 infection was suggested by several reports. We previously identified increased gene expression of actin-binding protein cofilin 1 (CFL1) in endocervix in the E2-dominated proliferative phase of the menstrual cycle. Actin cytoskeleton has an integral role in establishing and spreading HIV-1 infection. Herein, we studied in vitro effects of E2 on HIV-1 infection and on CFL1 expression to gain insight into the mechanism of HIV-1 inhibition by E2. E2 dose-dependently inhibited HIV-1BaL infection in peripheral blood mononuclear cells (PBMCs) and endocervix. In PBMCs and endocervix, E2 increased protein expression of total CFL1 and phosphorylated CFL1 (pCFL1) and pCFL1/CFL1 ratios. LIMKi3, a LIM kinase 1 and 2 inhibitor, abrogated the phenotype and restored infection in both PBMCs and endocervix; inhibited E2-induced expression of total CFL1, pCFL1; and decreased pCFL1/CFL1 ratios. Knockdown of CFL1 in PBMCs also abrogated the phenotype and partially restored infection. Additional analysis of soluble mediators revealed decreased concentrations of pro-inflammatory chemokines CXCL10 and CCL5 in infected tissues incubated with E2. Our results suggest a link between E2-mediated anti-HIV-1 activity and expression of CFL1 in PBMCs and endocervical mucosa. The data support exploration of cytoskeletal signaling pathway targets for the development of prevention strategies against HIV-1.
first_indexed 2024-12-10T11:02:47Z
format Article
id doaj.art-c1e95df9c2594901b65fd98f8b7b9bb1
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-10T11:02:47Z
publishDate 2022-04-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-c1e95df9c2594901b65fd98f8b7b9bb12022-12-22T01:51:38ZengNature PortfolioScientific Reports2045-23222022-04-0112111310.1038/s41598-022-10163-6Estradiol inhibits HIV-1BaL infection and induces CFL1 expression in peripheral blood mononuclear cells and endocervical mucosaN. Verma0S. Mukhopadhyay1P. Barnable2M. G. Plagianos3N. Teleshova4Center for Biomedical Research, Population CouncilCenter for Biomedical Research, Population CouncilCenter for Biomedical Research, Population CouncilCenter for Biomedical Research, Population CouncilCenter for Biomedical Research, Population CouncilAbstract An inhibitory effect of estradiol (E2) on HIV-1 infection was suggested by several reports. We previously identified increased gene expression of actin-binding protein cofilin 1 (CFL1) in endocervix in the E2-dominated proliferative phase of the menstrual cycle. Actin cytoskeleton has an integral role in establishing and spreading HIV-1 infection. Herein, we studied in vitro effects of E2 on HIV-1 infection and on CFL1 expression to gain insight into the mechanism of HIV-1 inhibition by E2. E2 dose-dependently inhibited HIV-1BaL infection in peripheral blood mononuclear cells (PBMCs) and endocervix. In PBMCs and endocervix, E2 increased protein expression of total CFL1 and phosphorylated CFL1 (pCFL1) and pCFL1/CFL1 ratios. LIMKi3, a LIM kinase 1 and 2 inhibitor, abrogated the phenotype and restored infection in both PBMCs and endocervix; inhibited E2-induced expression of total CFL1, pCFL1; and decreased pCFL1/CFL1 ratios. Knockdown of CFL1 in PBMCs also abrogated the phenotype and partially restored infection. Additional analysis of soluble mediators revealed decreased concentrations of pro-inflammatory chemokines CXCL10 and CCL5 in infected tissues incubated with E2. Our results suggest a link between E2-mediated anti-HIV-1 activity and expression of CFL1 in PBMCs and endocervical mucosa. The data support exploration of cytoskeletal signaling pathway targets for the development of prevention strategies against HIV-1.https://doi.org/10.1038/s41598-022-10163-6
spellingShingle N. Verma
S. Mukhopadhyay
P. Barnable
M. G. Plagianos
N. Teleshova
Estradiol inhibits HIV-1BaL infection and induces CFL1 expression in peripheral blood mononuclear cells and endocervical mucosa
Scientific Reports
title Estradiol inhibits HIV-1BaL infection and induces CFL1 expression in peripheral blood mononuclear cells and endocervical mucosa
title_full Estradiol inhibits HIV-1BaL infection and induces CFL1 expression in peripheral blood mononuclear cells and endocervical mucosa
title_fullStr Estradiol inhibits HIV-1BaL infection and induces CFL1 expression in peripheral blood mononuclear cells and endocervical mucosa
title_full_unstemmed Estradiol inhibits HIV-1BaL infection and induces CFL1 expression in peripheral blood mononuclear cells and endocervical mucosa
title_short Estradiol inhibits HIV-1BaL infection and induces CFL1 expression in peripheral blood mononuclear cells and endocervical mucosa
title_sort estradiol inhibits hiv 1bal infection and induces cfl1 expression in peripheral blood mononuclear cells and endocervical mucosa
url https://doi.org/10.1038/s41598-022-10163-6
work_keys_str_mv AT nverma estradiolinhibitshiv1balinfectionandinducescfl1expressioninperipheralbloodmononuclearcellsandendocervicalmucosa
AT smukhopadhyay estradiolinhibitshiv1balinfectionandinducescfl1expressioninperipheralbloodmononuclearcellsandendocervicalmucosa
AT pbarnable estradiolinhibitshiv1balinfectionandinducescfl1expressioninperipheralbloodmononuclearcellsandendocervicalmucosa
AT mgplagianos estradiolinhibitshiv1balinfectionandinducescfl1expressioninperipheralbloodmononuclearcellsandendocervicalmucosa
AT nteleshova estradiolinhibitshiv1balinfectionandinducescfl1expressioninperipheralbloodmononuclearcellsandendocervicalmucosa